Literature DB >> 2439023

Plasma alpha fetoprotein reference ranges in infancy: effect of prematurity.

J I Blair, R Carachi, R Gupta, F G Sim, E J McAllister, R Weston.   

Abstract

The dearth of plasma alpha fetoprotein reference ranges for preterm infants often impairs the clinical interpretation of plasma alpha fetoprotein data collected from ill babies. This study tested our hypothesis that meaningful plasma reference ranges could be established for preterm infants by a simple correction of patient age at sampling date for gestational age deficit at birth. Using a modified radioimmunoassay kit method, determinations of alpha fetoprotein were performed on capillary and venous blood samples collected from 56 babies aged from birth to 5 months with gestational ages ranging from 26 weeks to 43 weeks. Unmodified plasma alpha fetoprotein values were grouped according to patient age and examined statistically using established normal theory methods, but these yielded excessively wide reference intervals and non-Gaussian distribution parameters. Acceptable reference ranges were derived using logarithmic transformation of plasma alpha fetoprotein values and rearrangement against patient age corrected for gestational age deficit. These provisional reference ranges for plasma alpha fetoprotein in preterm (and term) infants are applied to groups of previously meaningless alpha fetoprotein results and used to test the potential usefulness of plasma alpha fetoprotein determination as a diagnostic marker in biliary atresia, hepatitis, and yolk sac derived tumours.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439023      PMCID: PMC1778344          DOI: 10.1136/adc.62.4.362

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Demonstration of a new protein fraction in serum from the human fetus.

Authors:  C G BERGSTRAND; B CZAR
Journal:  Scand J Clin Lab Invest       Date:  1956       Impact factor: 1.713

2.  Differentiation between neonatal hepatitis and biliary atresia by measuring serum-alpha-fetoprotein.

Authors:  P M Zeltzer; R C Neerhout; E W Fonkalsrud; E R Stiehm
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

3.  Postnatal changes of alpha-foetoprotein, albumin and total protein in human serum.

Authors:  B W Karlsson; C G Bergstrand; H Ekelund; T Lindberg
Journal:  Acta Paediatr Scand       Date:  1972-03

4.  Stability of alpha-fetoprotein in stored and frozen-thawed aliquots.

Authors:  D R Pollard; K Gupta
Journal:  Clin Biochem       Date:  1982-10       Impact factor: 3.281

5.  Yolk sac tumor (endodermal sinus tumor) and alpha-fetoprotein. A report of three cases.

Authors:  Y Tsuchida; S Saito; M Ishida; K Omi; Y Urano
Journal:  Cancer       Date:  1973-10       Impact factor: 6.860

6.  Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of "teratocarcinoma".

Authors:  B Norgaard-Pedersen; R Albrechtsen; G Teilum
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-11

7.  A study on alpha-fetoprotein and endodermal sinus tumor.

Authors:  Y Tsuchida; Y Urano; Y Endo; K Ohmi; K Hashizume
Journal:  J Pediatr Surg       Date:  1975-08       Impact factor: 2.545

8.  Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester.

Authors:  J E Haddow; E M Kloza; G J Knight; D E Smith
Journal:  Clin Chem       Date:  1981-01       Impact factor: 8.327

9.  Evaluation of alpha-fetoprotein in early infancy.

Authors:  Y Tsuchida; Y Endo; S Saito; M Kaneko; K Shiraki; K Ohmi
Journal:  J Pediatr Surg       Date:  1978-04       Impact factor: 2.545

10.  Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumours.

Authors:  J R Mann; G E Lakin; J C Leonard; H A Rawlinson; S G Richardson; J J Corkery; A H Cameron; K J Shah
Journal:  Arch Dis Child       Date:  1978-05       Impact factor: 3.791

View more
  7 in total

1.  Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.

Authors:  Kelly A Duffy; Jennifer L Cohen; Okan U Elci; Jennifer M Kalish
Journal:  J Pediatr       Date:  2019-06-22       Impact factor: 4.406

2.  Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy.

Authors:  Jennifer M Kalish; Laura K Conlin; Tricia R Bhatti; Holly A Dubbs; Mary Catherine Harris; Kosuke Izumi; Sogol Mostoufi-Moab; Surabhi Mulchandani; Sulagna Saitta; Lisa J States; Daniel T Swarr; Alisha B Wilkens; Elaine H Zackai; Kristin Zelley; Marisa S Bartolomei; Kim E Nichols; Andrew A Palladino; Nancy B Spinner; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2013-06-26       Impact factor: 2.802

3.  Intrahepatic hematoma: hepatic lesion in a newborn with high alpha-fetoprotein level.

Authors:  Chiu Ying Flora Lam; Kui Fai Chan; Tsz Wo Fan; Chong Hei Philip Kwok; Chi Hum Susan Chan; Tsz Kan Tsang
Journal:  Pediatr Radiol       Date:  2005-07-19

4.  Neonatal tumours: Glasgow 1955-86.

Authors:  C F Davis; R Carachi; D G Young
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

Review 5.  Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma.

Authors:  Jennifer M Kalish; Leslie Doros; Lee J Helman; Raoul C Hennekam; Roland P Kuiper; Saskia M Maas; Eamonn R Maher; Kim E Nichols; Sharon E Plon; Christopher C Porter; Surya Rednam; Kris Ann P Schultz; Lisa J States; Gail E Tomlinson; Kristin Zelley; Todd E Druley
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

Review 6.  Diagnosis and Management of Beckwith-Wiedemann Syndrome.

Authors:  Kathleen H Wang; Jonida Kupa; Kelly A Duffy; Jennifer M Kalish
Journal:  Front Pediatr       Date:  2020-01-21       Impact factor: 3.418

7.  Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis.

Authors:  Christopher J Stewart; Andrew Nelson; Achim Treumann; Tom Skeath; Stephen P Cummings; Nicholas D Embleton; Janet E Berrington
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.